COVID-19 is an airway disease that also affects the nervous system.1 Therefore, neurological and neurocognitive symptoms may be a part of the postacute sequelae of SARS-CoV-2 infection (PASC) syndrome. PASC may be found to affect a high proportion of people who had mild cases of COVID-19, and there is an urgent need for a detailed description of PASC in nonhospitalized patients.2,3 This cohort study examines self-reported memory problems 8 months after COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Søraas et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: